Bicara Therapeutics Common Stock OverviewBicara Therapeutics Common Stock Net Income
Profitability analysis for BCAX.
Quarterly Net Income
-$56.21M
↓ 52.56% YoY
As of Mar 2026
Annual Net Income (TTM)
-$157.31M
↓ 74.67% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...